Welcome to our dedicated page for BED BATH & BEYOND SEC filings (Ticker: BYON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BED BATH & BEYOND's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BED BATH & BEYOND's regulatory disclosures and financial reporting.
Bed Bath & Beyond Inc — The Vanguard Group amended its Schedule 13G/A reporting that it beneficially owns 0 shares of Common Stock as of 03/13/2026. The filing notes an internal realignment effective 01/12/2026 and states holdings reported herein would be in the form of warrants; the reporting entity has disaggregated subsidiary reporting per SEC Release No. 34-39538.
Bed Bath & Beyond director Joseph J. Tabacco Jr. reported an open-market purchase of 20,000 shares of Common Stock at a weighted average price of $5.11 per share. The shares were bought on March 10, 2026 in multiple trades between $5.07 and $5.13 per share.
The purchase was made indirectly through the Joseph Tabacco and Peggy Schmidt Revocable Trust, where he is trustee and beneficiary. After this transaction, the trust held 167,209 shares, and he also held 11,506 shares directly.
The filing also notes previously issued warrants from October 7, 2025, covering 1,150 shares directly and 14,720 shares indirectly, each exercisable for one share of common stock at an exercise price of $15.50 per warrant, with an expiration date of October 7, 2026.
Lee Adrianne reported acquisition or exercise transactions in this Form 4 filing.
Bed Bath & Beyond, Inc. President & CFO Adrianne Lee received a grant of 100,000 restricted stock units (RSUs), each representing a contingent right to one share of common stock. This is a compensation-related award, not an open-market stock purchase or sale.
The RSUs vest in three equal installments at the close of business on February 17, 2027, February 17, 2028 and February 17, 2029. Vested shares will be delivered to Lee promptly after each vesting date, and the 100,000 RSUs shown reflect the amount from this grant beneficially owned following the reported transaction.
Putnam Leah R reported acquisition or exercise transactions in this Form 4 filing.
BED BATH & BEYOND, INC. Chief Accounting Officer Leah R. Putnam reported receiving a grant of 40,000 restricted stock units (RSUs), each representing a right to one share of common stock. These RSUs vest in three equal installments on February 17, 2027, February 17, 2028, and February 17, 2029, with shares delivered promptly after each vesting date. Following this grant, she beneficially owns 40,000 RSUs from this award.
Bed Bath & Beyond executive chairman and CEO Marcus Lemonis reported a series of equity compensation transactions on March 10, 2026. He exercised 166,666 restricted stock units and 141,432 performance shares into an equal number of common shares at a conversion price of $0.00 per share.
He also received common stock awards of 166,666 and 141,432 shares, while 59,813 and 34,680 shares were withheld at $4.91 per share to cover tax obligations. After these vesting and tax-withholding transactions, Lemonis directly holds 669,756 shares of Bed Bath & Beyond common stock.
Bed Bath & Beyond Chief Accounting Officer Leah R. Putnam reported routine equity compensation activity. On March 2, 2026, 1,000 restricted stock units were exercised into 1,000 shares of common stock at a price of $0.00 per share. As part of the same event, 244 shares of common stock at $5.18 per share were withheld to cover tax obligations. Each restricted stock unit represents one share of common stock and vested in three equal installments on March 2, 2024, March 2, 2025 and March 2, 2026. Following these transactions, Putnam directly owned 16,554 shares of Bed Bath & Beyond common stock.
Bed Bath & Beyond, Inc. files its annual report outlining its evolution into an e‑commerce‑focused home retailer built around the Bed Bath & Beyond, Overstock, buybuy BABY and Kirkland’s brands. The company operates an asset‑light marketplace model, with most orders fulfilled by third‑party partners.
The report highlights an omni‑channel relaunch via a pending merger with The Brand House Collective (owner of converted Bed Bath & Beyond neighborhood stores), significant competition from large online and brick‑and‑mortar rivals, and reliance on digital marketing and search. It also notes an accumulated deficit of $842.7 million, equity method investments of $66.6 million, and a workforce of 389 employees as of December 31, 2025, supported by extensive human‑capital and culture initiatives.
Bed Bath & Beyond, Inc. reported fourth-quarter 2025 net revenue of $273 million, down 9.8% year-over-year, but continued its eighth straight quarter of measurable progress toward profitability. Gross margin improved to 24.6% and the quarterly net loss narrowed to $21 million, a $60 million improvement.
For full-year 2025, net revenue was $1.0 billion, down 25.1% year-over-year, while net loss narrowed to $85 million from $259 million and adjusted EBITDA loss improved to $31 million from $144 million. Operating cash flow use improved by $118 million and free cash flow improved to negative $64 million. The company expects low- to mid-single digit revenue growth in 2026 while maintaining disciplined margin and cost management.
Amplify Blockchain Technology ETF, a series of Amplify ETF Trust, reported a significant ownership stake in Bed Bath & Beyond, Inc. common stock. As of 12/31/2025, the fund beneficially owned 5,693,135 shares, representing about 8.3% of the outstanding common stock.
The ETF has sole power to vote and dispose of all these shares, with no shared voting or dispositive power. It states that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Bed Bath & Beyond.
Amplify Blockchain Technology ETF, a Massachusetts-based series of Amplify ETF Trust, filed an amended Schedule 13G reporting its ownership in Bed Bath & Beyond Inc. common stock. The filing states the fund now holds 5 percent or less of the company’s outstanding shares.
The ETF certifies that the Bed Bath & Beyond shares were acquired and are held in the ordinary course of business, not to change or influence control of the company, and not in connection with any control-related transaction. The ETF is a registered investment company, confirming a passive, institutional holder status.